Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients

CONTEXT: Therapy with somatostatin analogues (SSAs) may have deleterious effects on glucose metabolism in patients with acromegaly, often leading to the development of diabetes mellitus (DM). AIM: The aim of the study was to evaluate whether DM, developed during therapy with SSAs, may revert after d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappellani, Daniele, Urbani, Claudio, Sardella, Chiara, Scattina, Ilaria, Marconcini, Giulia, Lupi, Isabella, Manetti, Luca, Marcocci, Claudio, Bogazzi, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354758/
https://www.ncbi.nlm.nih.gov/pubmed/30815570
http://dx.doi.org/10.1002/edm2.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354758/
https://www.ncbi.nlm.nih.gov/pubmed/30815570
http://dx.doi.org/10.1002/edm2.33

Ejemplares similares